role
clinic
microbiologist
includ
identif
bacteri
viral
fungal
parasit
agent
caus
human
diseas
provid
diagnost
therapeut
support
clinic
manag
patient
prevent
transmiss
infecti
diseas
health
care
system
commun
number
identifi
emerg
infecti
diseas
steadili
climb
sinc
earli
twentyfirst
centuri
tool
pcr
highthroughput
mass
spectrometri
ms
along
new
sampl
cultur
strategi
chang
clinic
microbiolog
technolog
progress
began
environment
reveal
much
larger
microbi
world
believ
exist
year
ago
valid
bacteri
speci
publish
wherea
new
speci
describ
thu
past
year
new
bacteri
speci
describ
describ
period
fig
exampl
import
human
pathogen
helicobact
pylori
caus
gastric
ulcer
cancer
tropheryma
whipplei
caus
agent
whippl
diseas
first
isol
respect
virus
progress
compar
sever
acut
respiratori
syndrom
sar
associ
arenaviru
lujo
viru
caus
haemorrhag
identifi
respect
moreov
view
microbi
pathogenesi
one
given
microorgan
caus
one
given
diseas
view
inherit
pasteur
koch
began
chang
new
tool
allow
us
observ
divers
microorgan
impact
divers
human
diseas
exampl
know
nine
mycobacterium
speci
caus
tuberculosi
mycobacterium
bovi
requir
specif
antibiot
treatment
review
detail
main
chang
recent
occur
technolog
techniqu
avail
clinic
microbiolog
laboratori
cml
includ
syndrom
diseasebas
sampl
kit
pointofcar
poc
test
isol
type
character
ms
nextgener
sequenc
ng
also
tri
predict
import
develop
futur
syndrom
diseasebas
kit
convent
diagnosi
infecti
diseas
usual
reli
stepwis
approach
physician
examin
patient
diagnos
clinic
syndrom
test
pathogen
potenti
respons
syndrom
diagnosi
made
howev
grow
number
emerg
pathogen
make
difficult
physician
memor
actual
list
pathogen
infecti
diseas
thu
prescrib
appropri
diagnost
microbiolog
test
reduc
delay
associ
resampl
retest
sampl
carri
use
diagnost
kit
standard
accord
syndrom
diseas
strategi
enabl
optim
type
number
specimen
collect
patient
simplif
laboratori
test
prescript
physician
creation
schedul
workflow
nurs
doctor
also
allow
clinic
laboratori
easili
trace
sampl
date
diagnost
kit
develop
endocard
pericard
diarrhoea
osteiti
mening
enceph
uveiti
design
base
repertoir
pathogen
respons
syndrom
diseas
optim
method
achiev
direct
indirect
detect
identif
pathogen
syndromebas
kit
design
specif
group
febril
patient
present
emerg
room
poc
test
travel
pilgrim
mecca
saudi
arabia
homeless
patient
cystic
fibrosi
respiratori
tract
addit
broad
syndrom
diseasebas
kit
pathogenspecif
kit
use
pulmonari
compar
tradit
approach
common
agent
infecti
syndrom
test
first
follow
test
rarer
agent
broad
syndrom
diseasebas
strategi
might
seem
econom
disadvantag
possibl
increas
laboratori
cost
balanc
shorter
hospit
time
owe
earlier
diagnosi
earlier
initi
appropri
antibiot
therapi
avoid
unnecessari
treatment
case
viral
addit
specimen
recov
kit
preserv
biobank
retrospect
test
new
emerg
pathogen
describ
data
kit
usag
use
epidemiolog
analys
season
chang
sampl
evalu
costeffect
kit
date
cml
adopt
syndrom
diseasebas
kit
franc
exampl
use
univers
hospit
strain
collect
current
refer
microorgan
preserv
intern
collect
american
type
cultur
collect
deutsch
sammlung
von
mikroorganismen
und
zellkulturen
japan
collect
microorgan
howev
number
clinic
isol
routin
cultiv
cml
neither
conserv
refer
collect
conserv
clinic
isol
cml
might
enabl
trace
outbreak
character
emerg
pathogen
could
thu
valuabl
public
health
diseas
surveil
prevent
scientif
purpos
notabl
bacteri
strain
cultiv
normal
steril
organ
bodi
fluid
blood
cerebrospin
fluid
might
conserv
howev
cost
refer
laboratori
current
equip
longterm
storag
sampl
collect
identif
bacteria
fungi
virus
phenotyp
identif
bacteri
isol
long
reli
combin
biochem
properti
oxygen
requir
gram
stain
carbohydr
metabol
presenc
specif
enzym
howev
phenotyp
identif
system
miniatur
strip
costli
timeconsum
even
autom
thu
past
decad
supersed
ms
worldwid
mani
larg
cml
adopt
ms
owe
increas
workflow
effici
associ
cost
reduct
use
fig
ms
identifi
bacteri
isol
minut
minut
low
cost
per
strain
compar
per
strain
use
api
strip
vitek
autom
commonli
use
phenotyp
assay
per
strain
rrna
sequenc
moreov
approach
also
effici
identifi
clinic
isol
well
bacteria
blood
cultur
identif
microbi
isol
use
ms
reli
comparison
mass
spectrum
isol
mass
spectra
avail
databas
addit
rapid
low
cost
ms
advantag
includ
precis
identif
isol
speci
level
speci
subspeci
strain
level
current
bacteri
speci
mani
genera
identifi
ms
includ
fastidi
microorgan
review
ref
howev
discriminatori
power
method
vari
depend
speci
exhaust
databas
use
notabl
bacteri
taxa
underrepres
databas
technic
problem
variat
cultur
condit
sampl
prepar
spectromet
use
affect
discriminatori
power
addit
streptococci
nonfer
gramneg
bacteria
anaerob
bacteria
gener
harder
discrimin
bacteria
although
weak
partial
correct
enrich
avail
databas
spectra
ms
use
type
communityacquir
pathogen
listeria
monocytogen
legionella
pneumophila
yersinia
enterocolitica
health
careassoci
pathogen
corynebacterium
candida
commun
health
careassoci
pathogen
staphylococcu
aureu
final
ms
routin
use
sever
larg
cml
direct
identif
bacteria
blood
although
ms
identifi
variou
viral
commerci
avail
ms
databas
contain
viral
spectra
therefor
ms
yet
enabl
identif
virus
routin
microbiolog
recent
develop
highthroughput
phenotyp
microarray
biologu
system
biologu
inc
combin
phenotyp
test
might
challeng
lead
posit
ms
microarray
use
sever
applic
determin
bacteri
metabol
chemic
properti
formal
descript
new
speci
develop
optim
cultur
media
biologu
system
demonstr
highli
effici
phenotyp
identif
organ
although
less
discriminatori
rrna
slower
past
year
raman
spectroscopi
demonstr
accur
rapidli
identifi
bacteri
fungal
yeast
isol
speci
subspeci
method
light
scatter
laserillumin
bacteri
coloni
analys
transform
spectrum
compar
specif
databas
although
method
inexpens
reagentfre
rapid
ms
raman
spectroscopi
current
wide
use
cml
owe
technic
hurdl
low
signal
strength
perhap
also
owe
initi
cost
new
instrument
addit
ms
reliabl
raman
spectroscopi
depend
qualiti
coverag
refer
databas
detect
antibiot
resist
classic
method
phenotyp
antibioticsuscept
test
clinic
isol
base
minimum
inhibitori
concentr
mic
clinic
breakpoint
remain
gold
standard
vitro
predict
antibiot
resist
mani
factor
influenc
result
obtain
given
isol
lead
fals
posit
fals
neg
result
mic
defin
lowest
concentr
antibiot
abl
inhibit
growth
bacteri
isol
vitro
wherea
breakpoint
use
predict
clinic
outcom
antibiot
treatment
vivo
new
andor
emerg
resist
mechan
might
miss
easili
detect
phenotyp
vitro
instead
requir
addit
molecular
test
moreov
result
classic
resist
test
might
rapidli
avail
especi
fastidi
bacteria
applic
realtim
pcr
rtpcr
rapid
screen
detect
common
antibiot
resist
gene
meca
provid
resist
methicillin
carbapenem
bacteria
famili
respect
revolutionari
similar
manner
nonfluoresc
dna
detect
gene
mutat
snp
known
associ
tuberculosi
resist
antitubercul
compound
dna
microarray
anoth
new
technolog
detect
singl
step
mani
resist
gene
gramneg
gramposit
howev
microarray
expens
per
mb
microarray
versu
per
mb
highthroughput
genom
sequenc
detect
known
gene
recent
ms
also
use
clinic
rapid
phenotyp
detect
antibiot
resist
especi
exampl
possibl
detect
carbapenemas
activ
bacteria
famili
enterobacteriacea
pseudomona
aeruginosa
acinetobact
baumannii
identif
carbapenem
compound
degrad
product
ms
hour
high
sensit
fig
one
main
advantag
techniqu
enzymat
activ
associ
antibiot
resist
detect
even
caus
enzym
unknown
could
lead
discoveri
new
antibiot
resist
determin
addit
antibiot
resist
diagnost
improv
detect
interpret
resist
pattern
use
autom
intralaboratori
survey
antibiogram
allow
detect
unusu
phenotyp
emerg
cluster
strain
similar
profil
clinic
isol
recent
develop
comput
tool
realtim
surveil
weekli
basi
program
automat
systemat
compar
resist
pattern
obtain
clinic
sampl
routin
microbiolog
laboratori
microsoft
excel
databas
resist
pattern
base
result
clinic
isol
test
laboratori
aim
detect
atyp
abnorm
rare
pattern
resist
suscept
tool
might
improv
diagnosi
monitor
character
antibiot
resist
genom
sequenc
inform
cultiv
microorgan
wide
use
epidemiolog
studi
tabl
clinic
microbiolog
applic
genom
sequenc
includ
develop
detect
identif
genotyp
tool
design
cultur
media
assess
antibiot
resist
virul
recent
thank
ng
technolog
miseq
illumina
ion
torrent
person
genom
machin
pgm
life
technolog
gs
junior
roch
benchtop
sequenc
bacteri
genom
sequenc
becom
fast
hour
cheap
hundr
us
dollar
make
wholegenom
sequenc
compat
routin
clinic
microbiolog
strategi
might
offer
rapid
exhaust
access
virul
antibiot
resist
unusu
difficulttogrow
bacteri
strain
isol
clinic
specimen
recent
exampl
use
wholegenom
sequenc
clinic
microbiolog
includ
investig
hospit
outbreak
baumannii
aureu
clostridium
difficil
identif
virul
determin
staphylococcu
epidermidi
strain
aetiolog
agent
nativ
valv
addit
demonstr
recent
ng
might
also
enabl
complet
genom
sequenc
pathogen
directli
clinic
howev
despit
undeni
advantag
ng
requir
extens
bioinformat
sequenc
analysi
assembl
annot
remain
signific
problem
routin
applic
genom
clinic
microbiolog
develop
autom
tool
analysi
genom
sequenc
compil
databas
contain
whole
genom
sequenc
togeth
specif
genet
criteria
virul
factor
resist
marker
might
solv
problem
near
futur
enabl
ng
use
routin
addit
ng
use
begin
deciph
complex
human
microbi
commun
metagenom
furthermor
recent
analysi
gut
flora
provid
hint
might
enabl
predict
infect
suscept
antibiot
resist
assess
risk
develop
diseas
genotyp
genotyp
consist
trace
clone
identifi
sequencespecif
signatur
variou
genotyp
method
develop
includ
sever
method
base
dna
band
pattern
pulsedfield
gel
fragmentlength
polymorph
rflp
multipl
locu
variabl
number
tandem
repeat
analysi
mlva
random
amplif
use
arbitrari
primer
rapd
amplifi
fragmentlength
polymorph
aflp
howev
method
often
lack
reproduc
within
laboratori
dna
hybridizationbas
method
use
nucleotid
probe
dna
dna
expens
identifi
genet
marker
present
array
thu
might
underestim
genet
divers
among
bacteri
popul
dna
sequencebas
method
multilocu
sequenc
type
mlst
multispac
sequenc
genom
discriminatori
reproduc
timeconsum
expens
although
genotyp
pathogen
isol
cultur
would
probabl
signific
impact
infect
control
polici
execut
genotyp
techniqu
carri
routin
except
detect
specif
clone
certain
pathogen
exampl
tuberculosi
str
beij
detect
within
hour
use
specif
enabl
patient
isol
contact
trace
extend
antitubercul
treatment
mass
spectrometri
first
time
ms
report
effici
identifi
bacteria
directli
blood
collect
cultur
bottl
result
obtain
less
hour
blood
cultur
vial
determin
posit
success
fig
howev
accuraci
bacteri
identif
might
influenc
unstandard
sampl
prepar
differ
bacteri
concentr
preincub
prolong
incub
blood
cultur
system
commerci
avail
extract
implement
minimum
concentr
colonyform
unit
cfu
per
ml
ref
might
resolv
discrep
ms
also
use
direct
identif
bacteria
urin
sampl
accuraci
rate
bacteri
concentr
low
cfu
per
ml
ref
final
addit
identifi
bacteria
ms
shown
capabl
identifi
fungi
blood
cultur
nail
howev
ms
certain
limit
includ
inabl
identifi
speci
among
mix
popul
directli
solid
clinic
specimen
poor
discriminatori
power
among
corynebacteria
molecular
detect
molecular
detect
method
notabl
bacteri
pcr
combin
sequenc
play
major
part
clinic
microbiolog
enabl
discoveri
sever
noncultiv
pathogen
bartonella
quintana
among
molecular
diagnost
method
rtpcr
prove
highli
valuabl
enabl
diagnos
obtain
less
hour
wherea
tradit
microbiolog
method
includ
convent
molecular
diagnost
broad
pcr
follow
sequenc
take
minimum
day
rtpcr
also
enabl
quantif
routin
use
quantifi
viral
load
patient
infect
hiv
rtpcr
assay
target
either
specif
pathogen
resist
virulenceencod
gene
univers
target
rdna
bacteria
rdna
intern
transcrib
spacer
fungi
addit
rtpcr
multiplex
assay
simultan
target
sever
dna
fragment
thu
enabl
detect
whole
panel
pathogen
implic
particular
syndrom
bloodstream
communityacquir
pneumonia
sexual
transmit
urinari
tract
although
rtpcrmediat
detect
specif
agent
avoid
sequenc
convent
pcr
use
broadrang
target
combin
sequenc
remain
irreplac
tool
identif
new
pathogen
clinic
specimen
past
decad
pcr
amplicon
sequenc
increasingli
implement
cml
identif
genotyp
microbi
altern
ms
pcr
follow
electrospray
tof
ms
recent
applic
mass
spectrometri
enabl
bacteri
identif
follow
pcr
amplif
speciesspecif
dna
commerci
avail
technolog
form
plexid
machineri
abbott
identifi
import
human
pathogen
bacteria
includ
bacillu
anthraci
francisella
tularensi
yersinia
pesti
burkholderia
mallei
burkholderia
pseudomallei
brucella
spp
c
burnetii
along
influenza
viru
influenza
b
viru
howev
studi
need
valid
use
ms
routin
microbiolog
electron
nose
identifi
specif
combin
volatil
organ
compound
produc
microorgan
within
clinic
specimen
electron
nose
abl
detect
presenc
type
bacteria
respons
infecti
diseas
urinari
tract
pulmonari
infect
method
approach
thu
allow
earli
initi
appropri
antibiot
limit
electron
nose
quantifi
microorgan
within
specimen
therefor
discrimin
infect
colon
core
laboratori
sever
countri
concentr
cml
larg
core
laboratori
aim
lower
manag
cost
increas
number
routin
special
test
avail
variou
howev
organ
distanc
patient
doctor
laboratori
might
result
delay
report
test
result
inappropri
manag
patient
outbreak
shiga
toxinproduc
escherichia
coli
germani
countri
core
cml
creat
highlight
risk
delay
report
clinic
pointofcar
laboratori
need
autom
workflow
improv
made
necessari
central
biomed
analys
increas
distanc
laboratori
site
patient
care
well
batch
process
clinic
specimen
result
delay
deliveri
result
consequ
core
cml
unabl
contribut
time
decisionmak
infecti
diseas
contrast
poc
laboratori
pocl
onsit
laboratori
carri
rapid
diagnost
test
within
hour
compar
hour
cultur
method
serolog
assay
oper
around
clock
laboratori
perfectli
adapt
provid
result
earli
stage
patient
care
help
make
appropri
hospit
isol
therapi
decis
fig
initi
poc
test
reli
immunochromatograph
agglutin
assay
howev
latest
autom
dna
extract
rtpcr
devic
use
simplifi
procedur
made
molecular
detect
assay
compat
poc
object
date
sever
poc
test
immunochromatograph
detect
streptococcu
pyogen
antigen
throat
plasmodium
falciparum
blood
demonstr
use
physician
offic
board
ship
visit
malariaendem
countri
dr
unpublish
observ
pocl
provid
accur
rapid
answer
limit
number
clinic
microbiolog
question
clear
impact
patient
poc
assay
address
requir
hospit
patient
isol
contagi
individu
initi
focu
antiinfect
therapi
assay
routin
use
pocl
includ
develop
detect
bacteria
exampl
bordetella
pertussi
c
difficil
neisseria
meningitidi
streptococcu
pneumonia
pyogen
virus
includ
adenovirus
dengu
viru
enterovirus
influenza
virus
parasit
p
falciparum
earli
studi
demonstr
onsit
pocl
met
physician
need
influenc
manag
patient
present
emerg
strategi
might
repres
major
evolut
decisionmak
regard
manag
infecti
diseas
patient
care
particular
demonstr
pocl
strategi
enabl
rapid
adapt
antibiot
therapi
patient
bacteri
mening
reduc
length
hospit
stay
patient
viral
typic
pocl
featur
operatorindepend
test
includ
rtpcr
immunochromatograph
assay
clear
us
food
drug
administr
european
commiss
compar
standard
microbiolog
procedur
poc
test
high
posit
predict
valu
lack
syndromebas
kit
also
use
pocl
rapid
diagnosi
respiratori
tract
sexual
transmit
result
immedi
transmit
physician
sm
hospit
inform
system
pocl
easili
implement
type
environ
includ
remot
area
demonstr
recent
develop
pocl
rural
furthermor
test
panel
even
adapt
local
epidemiolog
autom
cml
face
common
constraint
includ
need
process
increas
number
sampl
increas
number
assay
per
sampl
need
maintain
continu
workflow
sometim
even
pressur
reduc
human
resourc
mani
assay
character
repetit
manual
oper
partial
full
autom
reduc
human
intervent
increas
qualiti
result
reduc
human
error
thu
improv
workflow
output
year
cml
autom
variou
task
blood
cultur
monitor
biochem
phenotyp
identif
bacteria
yeast
antibioticsuscept
test
gram
stain
dna
extract
pcr
amplif
autom
earli
detect
posit
blood
cultur
identif
pathogen
antimicrobi
suscept
significantli
reduc
mortal
patient
bacteraemia
among
import
function
howev
like
ms
autom
progress
replac
phenotyp
microbi
one
recent
advanc
autom
develop
plate
streaker
coupl
bidirect
interfac
laboratori
inform
system
possibl
inocul
differ
plate
uniqu
sampl
date
three
avail
autom
system
previ
isola
wasp
walkaway
specimen
processor
copan
inoqula
kiestra
allow
better
cfu
recoveri
manual
howev
specimen
except
urin
specimen
requir
timeconsum
pretreat
fluid
sputum
sampl
prepar
solid
specimen
grind
use
specif
expens
swab
concomitantli
increas
need
freez
store
sampl
biobank
inocul
dna
extract
therefor
futur
gener
autom
plate
streaker
incorpor
function
aliquot
dna
extract
connect
autom
dna
extract
andor
amplif
system
genexpert
system
cepheid
final
aim
complet
autom
system
coupl
autom
urinari
flow
autom
incub
adapt
atmospher
current
fulli
autom
kiestra
platform
partial
allow
addit
step
follow
incub
plate
sort
accord
posit
coloni
pick
ms
identif
antimicrobialsuscept
test
also
autom
automat
incub
plate
sorter
current
develop
yet
avail
system
discard
minimum
neg
sampl
similar
blood
cultur
autom
system
would
allow
signific
time
save
laboratori
sampl
inocul
annual
steril
autom
coloni
pick
enabl
ms
identif
antimicrobialsuscept
test
alreadi
avail
use
kiestra
qualiti
assur
qualiti
control
cml
implement
system
qualiti
manag
monitor
aspect
pre
postanalyt
servic
provid
cml
receipt
patient
sampl
report
ideal
accord
common
intern
standard
organ
iso
framework
addit
organiz
technic
oper
procedur
standard
made
perman
avail
laboratori
personnel
updat
quarterli
basi
moreov
laboratori
particip
extern
intern
qualityassur
scheme
result
interpret
report
essenti
manag
infecti
diseas
patient
commun
level
thu
constant
prioriti
cml
health
author
interpret
patient
manag
essenti
laboratori
provid
reliabl
result
clinician
trust
therefor
correct
interpret
microbiolog
result
crucial
interpret
improv
autom
interpret
softwar
report
unknown
imposs
phenotyp
genotyp
autom
system
phoenix
becton
dickinson
co
enabl
detect
bacteri
isol
either
taxonom
unusu
certain
clinic
syndrom
specimen
type
exhibit
new
rare
antibiot
resist
profil
cml
either
use
commerci
avail
ms
spectrum
databas
bruker
daltonik
shimadzu
identifi
bacteri
isol
develop
addit
result
genotyp
method
compar
onlin
databas
three
surveil
system
updat
result
laboratori
laboratori
medic
microbiologist
valid
result
help
tool
survey
intern
scientif
literatur
result
transmit
clinician
report
earli
report
microbiolog
result
prioriti
cml
particular
critic
result
posit
direct
examin
cultur
pcr
blood
cerebrospin
fluid
tissu
faster
report
identif
antimicrobialsuscept
result
significantli
reduc
length
hospit
stay
overal
cours
faster
report
impli
cml
follow
technolog
progress
equip
fastest
microbiolog
report
carri
use
laboratori
inform
system
electron
dashboard
mobil
phone
oral
sm
commun
therebi
enabl
physician
receiv
time
alert
centr
follow
develop
pocl
implement
smsbase
transmiss
result
inform
physician
quickli
possibl
physician
might
also
use
person
inform
system
access
laboratori
clinicalpati
data
local
epidemiolog
data
anoth
import
aspect
report
warn
local
nation
intern
medic
commun
cdc
european
centr
diseas
prevent
control
ecdc
case
emerg
unusu
infecti
diseas
epidem
potenti
alert
websit
program
monitor
emerg
diseas
promedmail
european
travel
medicin
network
eurotravnet
journal
eurosurveil
suitabl
channel
alert
introduct
omic
technolog
genom
proteom
culturom
transcriptom
metabolom
cml
face
new
challeng
obtain
diagnosi
time
care
fig
exampl
recent
use
blood
cultur
emerg
room
limit
result
identif
antibioticsuscept
test
avail
hour
condit
either
empir
prescrib
antibiot
treatment
effect
chang
anoth
treatment
worstcas
scenario
patient
death
diagnosi
establish
clearli
cml
major
impact
earli
patient
manag
diagnost
speed
enabl
appropri
medic
decis
made
rapidli
term
treatment
rapid
pathogen
identif
combin
knowledg
patient
contract
infect
exampl
whether
hospit
acquir
commun
acquir
enabl
presumpt
deduct
antimicrobi
suscept
antibiot
stewardship
base
rapid
diagnost
reduc
hospit
anoth
crucial
challeng
clinic
microbiolog
time
need
cost
reduct
favour
laboratori
concentr
avoid
disconnect
core
cml
clinic
set
preserv
perman
interact
clinic
microbiologist
primari
care
physician
ensur
time
report
proper
result
interpret
optim
therapi
manag
case
outbreak
cml
play
import
part
warn
medic
author
corrobor
result
across
particular
region
countri
contin
laboratori
detect
emerg
unknown
speci
particular
pathotyp
antibiot
resist
thu
detect
develop
outbreak
rapidli
earli
inform
share
mandatori
outbreak
control
demonstr
global
outbreak
cotrimoxazoleresist
e
coli
sourc
remain
mysteri
although
link
poultri
cml
also
role
syndrom
surveil
monitor
type
specimen
associ
syndrom
alert
lead
discoveri
unexplain
ill
exampl
increas
number
cerebrospin
fluid
sampl
refer
laboratori
absenc
aetiolog
label
outbreak
mening
alert
laboratori
technician
prompt
search
new
pathogen
likewis
emerg
atyp
organ
must
report
warn
system
promedmail
eurotravnet
probabl
also
nation
european
level
date
europ
lack
central
organ
warn
system
addit
larg
laboratori
act
strain
repositori
although
european
american
japanes
refer
strain
collect
exist
collect
pathogen
microorgan
detect
cml
extend
conserv
clinic
strain
interest
moreov
larg
cml
educ
role
offer
train
uptod
cours
current
use
evolv
technolog
final
cml
identifi
character
microbi
pathogen
sequenc
genom
involv
scientif
discoveri
gener
also
import
impact
scientif
literatur
